Kreuter, Michael
Swigris, Jeff
Pittrow, David
Geier, Silke
Klotsche, Jens
Prasse, Antje
Wirtz, Hubert
Koschel, Dirk
Andreas, Stefan
Claussen, Martin
Grohé, Christian
Wilkens, Henrike
Hagmeyer, Lars
Skowasch, Dirk
Meyer, Joachim F.
Kirschner, Joachim
Gläser, Sven
Kahn, Nicolas
Welte, Tobias
Neurohr, Claus
Schwaiblmair, Martin
Held, Matthias
Bahmer, Thomas
Oqueka, Tim
Frankenberger, Marion
Behr, Jürgen
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 11 December 2018
Accepted: 27 February 2019
First Online: 15 March 2019
Ethics approval and consent to participate
: The study materials were approved by the Ethics Committee of the Medical Faculty, Technical University of Dresden (EK 255082012), and by further local ethic committees as per local requirements.
: Not applicable.
: MK reports grants and personal fees from Roche/InterMune, grants and personal fees from Boehringer Ingelheim, outside the submitted work; AP reports grants and personal fees from Roche/InterMune, grants and personal fees from Boehringer Ingelheim, outside the submitted work; HuWi reports personal fees from Boehringer Ingelheim, and personal fees from Roche, outside the submitted work; MC reports honoraria for lectures from Boehringer Ingelheim Pharma GmbH and Roche Pharma, and for serving on advisory boards from Boehringer Ingelheim, outside the submitted work; DP reports personal fees outside the submitted work from Actelion, Bayer, Boehringer Ingelheim, Sanofi, Biogen, Shield and MSD; DS reports personal fees from Boehringer Ingelheim, Roche, outside the submitted work; SV reports personal fees from Boehringer Ingelheim, personal fees from Roche Pharma, personal fees from Actelion Pharma, grants and personal fees from Novartis Pharma, personal fees from Berlin Chemie, and personal fees from Astra, outside the submitted work; HeWi reports personal fees from Boehringer, personal fees from Roche, during the conduct of the study; personal fees from Bayer, personal fees from Biotest, personal fees from Actelion, personal fees from GSK, and personal fees from Pfizer, outside the submitted work; CN reports honoraria for lectures and serving on advisory boards from Boehringer Ingelheim and Roche Pharma; SA reports case payments from Boehringer Ingelheim, during the conduct of the study; personal fees from Boehringer Ingelheim, and personal fees from Roche, outside the submitted work; SG reports personal fees from Boehringer Ingelheim, personal fees from Roche Pharma, personal fees from Actelion Pharma, grants and personal fees from Novartis Pharma, personal fees from Berlin Chemie, and personal fees from Astra, all outside the submitted work; TW reports grants from Boehringer, during the conduct of the study; TB reports grants from German Center for Lung Research (DZL), personal fees for consultation or lecture from Roche, AstraZeneca, Chiesi, GSK, and Novartis outside the submitted work; JB received grants from Boehringer Ingelheim, and personal fees for consultation or lectures from Actelion, Bayer, Boehringer-Ingelheim, and Roche. He is member of the national and international IPF guideline committee; All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.